Cure51's CEO Nicolas Wolikow: How does AI help advance our Rosalind Study?

Rosalind Study

Inside Cure51

The science

Publication Date:

How does AI help advance our Rosalind Study? Our CEO Nicolas Wolikow breaks it down in an interview with FW.MEDIA.

Credit: FW.MEDIA

Nicolas Wolikow, CEO


Updated: April 1, 2026

NEWS